How to address the complexity of multi-targeted drug discovery for Alzheimer's disease?

González, Juan F; Sánchez-Montero, José M

González, Juan F; Sánchez-Montero, José M.

Affiliation

González JF; Department of Chemistry in Pharmaceutical Sciences, Faculty of Pharmacy, Complutense University of Madrid, Madrid, Spain.
Sánchez-Montero JM; Department of Chemistry in Pharmaceutical Sciences, Faculty of Pharmacy, Complutense University of Madrid, Madrid, Spain.

Expert Opin Drug Discov ; 19(10): 1149-1152, 2024 Oct.

Article in En | MEDLINE | ID: mdl-39075884

Subject(s)

Alzheimer Disease; Drug Discovery; Molecular Targeted Therapy; Alzheimer Disease/drug therapy; Alzheimer Disease/physiopathology; Humans; Drug Discovery/methods; Animals; Drug Development/methods

Key words

Alzheimer's disease; artificial intelligence; multi-target drugs; polypharmacology; therapeutic synergies

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Discovery / Molecular Targeted Therapy / Alzheimer Disease Limits: Animals / Humans Language: En Journal: Expert Opin Drug Discov / Expert opin. drug discov. (Online) / Expert opinion on drug discovery (Online) Year: 2024 Document type: Article Affiliation country: Spain Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google